ResearcherThe First Hospital of KunmingActive in the last 2 years

Xin Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-9893-5514; OpenAlex author ID A5116748771. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2025: 1 paper

Papers 1

miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. Last author DOI 10.4149/gpb_2024047 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jiayun Ge · 1 shared paper, 2025 · strength 0.27
- Paper miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. DOI 10.4149/gpb_2024047 ↗
Bo Tang · 1 shared paper, 2025 · strength 0.27
- Paper miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. DOI 10.4149/gpb_2024047 ↗
Zhihong Zhang · 1 shared paper, 2025 · strength 0.27
- Paper miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. DOI 10.4149/gpb_2024047 ↗
Renchao Zou · 1 shared paper, 2025 · strength 0.27
- Paper miR-145-5p modulates CDCA3 to overcome gemcitabine resistance in pancreatic cancer. DOI 10.4149/gpb_2024047 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.